J&J latest pharma firm to volunteer pricing data

Johnson & Johnson released its pricing data, as promised, in February and it has simply revealed that its average price increases have been below the 10% mark annually for the last five years. It follows a similar path trodden by MSD, known as Merck in North America, in the release of a brief table of price increases but levelled against the ‘Net Price Change’ that factors in rebates and reimbursements.
read more http://www.pharmafile.com/news/513441/jj-latest-pharma-firm-volunteer-pricing-data